Biomarkers of Remission in Rheumatoid Arthritis (BioRRA)
Launched by NEWCASTLE-UPON-TYNE HOSPITALS NHS TRUST · Aug 15, 2014
Trial Information
Current as of May 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of rheumatoid arthritis made by consultant rheumatologist at least 12 months previously
- • Current single or combination use of methotrexate, sulphasalazine and/or hydroxychloroquine
- • Arthritis currently in remission, as judged clinically by referring healthcare professional
- • Willing to consider DMARD withdrawal
- Exclusion Criteria:
- • Use of biologic therapy within the past 6 months
- • Received steroids within past 3 months (enteral, parenteral or intra-articular)
- • Use of any DMARD other than methotrexate, sulphasalazine or hydroxychloroquine within the past 6 months (or past 12 months for leflunomide)
- • Current pregnancy, or pregnancy planned within next 6 months
- • Current participation within another clinical trial
- • Inability to provide informed consent
About Newcastle Upon Tyne Hospitals Nhs Trust
The Newcastle-upon-Tyne Hospitals NHS Trust is a leading healthcare organization in the UK, renowned for its commitment to delivering high-quality patient care and advancing medical research. As a prominent clinical trial sponsor, the Trust leverages its extensive expertise in various medical specialties to facilitate innovative research initiatives aimed at improving treatment outcomes and enhancing healthcare practices. With a strong focus on collaboration and ethical standards, the Trust actively engages with academic institutions and industry partners to drive scientific discovery and translate findings into clinical applications that benefit patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newcastle Upon Tyne, Tyne & Wear, United Kingdom
Patients applied
Trial Officials
John D Isaacs, PhD MBBS
Principal Investigator
Newcastle University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials